表紙
市場調查報告書

手術用人工血管:醫療設備的開發平台評估

Vascular Grafts - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 346859
出版日期 內容資訊 英文 85 Pages
訂單完成後即時交付
價格
手術用人工血管:醫療設備的開發平台評估 Vascular Grafts - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年10月31日內容資訊: 英文 85 Pages
簡介

本報告提供手術用人工血管的開發中產品調查分析,以各開發階段比較分析為焦點,提供開發中產品的開發中主要企業,進行中的臨床試驗相關資訊等系統性資訊。

第1章 目錄

第2章 簡介

  • 手術用人工血管概要

第3章 開發中的產品

  • 手術用人工血管 - 開發中產品:各開發階段
  • 手術用人工血管 - 開發中產品:各地區
  • 手術用人工血管 - 開發中產品:各法規
  • 手術用人工血管 - 開發中產品:各核准預定日
  • 手術用人工血管 - 進行中的臨床試驗

第4章 手術用人工血管 - 正在開發的開發中產品:各企業

  • 手術用人工血管企業 - 開發中產品:各開發階段
  • 手術用人工血管 - 開發中產品:各開發階段

第5章 手術用人工血管企業與產品概要

  • 3S BioMedical, Inc.
  • Anethon (Inactive)
  • ARISTE Medical
  • Cardiojustable LLC
  • CryoLife, Inc.
  • DSM Biomedical B.V.
  • Eqalix, Inc.
  • FIT Biotech Oy
  • Gel-Del Technologies, Inc.
  • Graftworx, LLC
  • Healionics Corporation
  • Innovia LLC
  • MultiGene Vascular Systems (MGVS) Ltd.
  • NuVascular Technologies Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • SurgaColl Technologies Ltd
  • Universidad de Los Andes
  • VesselTek BioMedical LLC
  • Xeltis AG

第6章 手術用人工血管 - 最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1015EPD

GlobalData's Medical Devices sector report, "Vascular Grafts - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Vascular Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Vascular Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vascular Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Vascular Grafts Overview

3 Products under Development

  • 3.1 Vascular Grafts - Pipeline Products by Stage of Development
  • 3.2 Vascular Grafts - Pipeline Products by Segment
  • 3.3 Vascular Grafts - Pipeline Products by Territory
  • 3.4 Vascular Grafts - Pipeline Products by Regulatory Path
  • 3.5 Vascular Grafts - Pipeline Products by Estimated Approval Date
  • 3.6 Vascular Grafts - Ongoing Clinical Trials

4 Vascular Grafts - Pipeline Products under Development by Companies

  • 4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development
  • 4.2 Vascular Grafts - Pipeline Products by Stage of Development

5 Vascular Grafts Companies and Product Overview

  • 5.1 3DT Holdings LLC Company Overview
    • 5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Andes University Company Overview
    • 5.2.1 Andes University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Angiograft LLC Company Overview
    • 5.3.1 Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Ariste Medical LLC Company Overview
    • 5.4.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Aruga Technologies LLC Company Overview
    • 5.5.1 Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 BioIntegral Surgical Inc Company Overview
    • 5.6.1 BioIntegral Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Biosurfaces Inc Company Overview
    • 5.7.1 Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Cardiojustable LLC (Inactive) Company Overview
    • 5.8.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Cardiovate Company Overview
    • 5.9.1 Cardiovate Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Colorado Therapeutics, LLC Company Overview
    • 5.10.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 CryoLife Inc Company Overview
    • 5.11.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Cytograft Tissue Engineering Inc (Inactive) Company Overview
    • 5.12.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 DSM Biomedical BV Company Overview
    • 5.13.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Eqalix Inc Company Overview
    • 5.14.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 FIT Biotech Oy (Inactive) Company Overview
    • 5.15.1 FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Gel-Del Technologies, Inc. Company Overview
    • 5.16.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Humacyte Inc Company Overview
    • 5.17.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Innovia LLC Company Overview
    • 5.18.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 LeMaitre Vascular Inc Company Overview
    • 5.19.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 Merit Medical Systems Inc Company Overview
    • 5.20.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Nationwide Children's Hospital Company Overview
    • 5.21.1 Nationwide Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 Northwestern University Company Overview
    • 5.22.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 Peca Labs Inc Company Overview
    • 5.23.1 Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 PetVivo Holdings Inc Company Overview
    • 5.24.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 PQ Bypass Inc Company Overview
    • 5.25.1 PQ Bypass Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 RegenaGraft Company Overview
    • 5.26.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 RUA Vascular Ltd Company Overview
    • 5.27.1 RUA Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 Secant Group LLC Company Overview
    • 5.28.1 Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Terumo Aortic Company Overview
    • 5.29.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 Tgen Tech LLC Company Overview
    • 5.30.1 Tgen Tech LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 TTK Healthcare Ltd Company Overview
    • 5.31.1 TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 University of Louisville Company Overview
    • 5.32.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 University of Pittsburgh Company Overview
    • 5.33.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 Vascudyne Inc Company Overview
    • 5.34.1 Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 VenoStent Inc Company Overview
    • 5.35.1 VenoStent Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36 VesselTek BioMedical LLC Company Overview
    • 5.36.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37 VESSL Therapeutics Ltd Company Overview
    • 5.37.1 VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Vascular Grafts- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Vascular Grafts - Pipeline Products by Stage of Development
  • Table 2: Vascular Grafts - Pipeline Products by Segment
  • Table 3: Vascular Grafts - Pipeline Products by Territory
  • Table 4: Vascular Grafts - Pipeline Products by Regulator

List of Figures

List of Figures

  • Figure 1: Vascular Grafts - Pipeline Products by Stage of Development
  • Figure 2: Vascular Grafts - Pipeline Products by Segment
  • Figure 3: Vascular Grafts - Pipeline Products by Territory
  • Figure 4: Vascular Grafts - Pipeline Products by Regulatory Path
  • Figure 5: Vascular Grafts - Pipeline Products by Estimated Approval Date
  • Figure 6: Vascular Grafts - Ongoing Clinical Trials